...
首页> 外文期刊>Retina >Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration.
【24h】

Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration.

机译:与年龄相关的黄斑变性继发的大量视网膜下出血后的手术结局。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Massive subretinal hemorrhage (SRH), defined as a thick submacular bleed that extends past the equator in at least two quadrants, is a rare sequela of age-related macular degeneration. This report describes outcomes after surgical intervention for massive SRH. METHODS: The study design is a retrospective interventional case series. Records of consecutive patients who underwent surgical intervention for massive SRH were reviewed. Outcomes included change from baseline in postoperative acuity at Months 1, 3, 6, 9, and 12 and postoperative complications. RESULTS: Fifteen consecutive eyes of 13 patients who underwent surgery for massive SRH were included. Procedures performed on initial surgery included subretinal instillation of 25 mug/0.1 mL tissue plasminogen activator (15 of 15), gas tamponade (12 of 15), oil tamponade (3 of 15), 180 degrees or greater retinotomy (4 of 15), and/or cataract extraction (2 of 15). Patients were followed for a median of 20 months (range, 3-66 months). The median visual acuity at baseline and postoperative Month 1 was hand motions but improved to counting fingers at postoperative Months 3 (P = 0.04), 6 (P = 0.04), 9 (P = 0.04), and 12 (P = 0.10). Of the 15 eyes, 9 required at least 1 additional procedure for an indication of hyphema and/or vitreous hemorrhage (n = 6), retinal detachment (n = 2), glaucoma (n = 1), cataract (n = 1), and aphakia (n = 1). At the time of the onset of SRH, 5 of 13 patients were anticoagulated with warfarin (4 patients) or clopidogrel (1 patient), and 1 was diagnosed with a coagulopathy, factor XI deficiency. CONCLUSION: Massive SRH related to age-related macular degeneration has a grave prognosis. Risk factors may include anticoagulation and coagulopathy. Limitations of the study include its retrospective nature, small sample size, imprecision in acuity measurements below 20/400, and lack of a control group. In this series, surgical intervention was associated with a modest improvement in median visual acuity up to 1 year postoperatively.
机译:目的:大规模视网膜下出血(SRH)是指与年龄相关的黄斑变性的罕见后遗症,其定义为至少在两个象限处延伸超过赤道的黄斑下出血。该报告描述了大规模SRH的外科手术干预后的结果。方法:研究设计是回顾性介入病例系列。回顾了连续手术患者接受大量SRH的记录。结果包括第1、3、6、9和12个月的术后视力基线变化和术后并发症。结果:包括13例接受过大量SRH手术的患者的15个连续眼睛。初次手术时所进行的操作包括:视网膜下滴注25杯/0.1 mL组织纤溶酶原激活剂(15中的15),气填塞(15中的12),油填塞(15中的3),180度或更高的视网膜切开术(15中的4),和/或白内障摘除(15之2)。随访患者的中位数为20个月(范围3-66个月)。基线和术后第1个月的中位视力为手部动作,但在术后第3个月(P = 0.04),第6个月(P = 0.04),9(P = 0.04)和12个月(P = 0.10)可以改善手指计数。在15眼中,有9眼至少需要进行1次附加手术,以指示前房和/或玻璃体出血(n = 6),视网膜脱离(n = 2),青光眼(n = 1),白内障(n = 1),和无晶状体(n = 1)。在SRH发作时,13例患者中有5例用华法令抗凝剂(4例)或氯吡格雷(1例患者)进行了抗凝,1例被诊断患有凝血因子XI缺乏症。结论:与年龄相关的黄斑变性相关的大量SRH具有严重预后。危险因素可能包括抗凝和凝血病。该研究的局限性包括其回顾性,样本量小,低于20/400的敏锐度测量结果不准确以及缺乏对照组。在本系列中,手术干预与术后1年中位视力的适度改善有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号